Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Embelin
Cat. No.:
OB0225LY-0478
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR and HPLC.
Size:
Add to basket
Product Overview
Description:
Embelin is an inhibitor of the X-linked inhibitor of apoptosis.
Synonym:
NSC 91874; Emberine; Embelic acid; 550-24-3; 2,5-Dihydroxy-3-undecylcyclohexa-2,5-diene-1,4-dione; 2,5-Dihydroxy-3-undecyl-1,4-benzoquinone; 2,5-Dihydroxy-3-undecyl-p-benzoquinone
CAS No.:
550-24-3
Compound CID:
3218
Formula:
C17H26O4
Formula Weight:
294.39
Specification
Source:
Japanese Ardisia herb
Relative Density:
1.131 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Embelin can be used for drug screening or play an important role in anti-inflammatory research.
Library Information
Targets:
IAPs; Inflammatory enzymes; Transcription factors
Receptors:
5-Lipoxygenase; Prostaglandin receptor; IAP; mPGES-1; NF-κB; XIAP
Pathways:
Autophagy; Immunology/Inflammation; Apoptosis; GPCR/G protein; Metabolism; NF-κB
Plate Number:
AOCL-7
Plate Location:
b7
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
29.4 mg/mL; 100 mM
Ethanol Max Solubility:
2.9 mg/mL; 10 mM
